Ceptyr
company
About
Ceptyr is a developer of protein tyrosine phosphatase (PTP) -based therapeutics.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $11.50M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 1995
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$31.50M
Ceptyr has raised a total of
$31.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 23, 2002 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 23, 2002 | Series Unknown | $20M | 1 | — | — | Detail |
| Aug 18, 1999 | Series Unknown | $11.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Ceptyr is funded by 2 investors.
ARCH Venture Partners
and Falcon
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series Unknown |
Falcon
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
